Matthew K. Fust - 04 Nov 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Director
Signature
/s/ David Tucker, Attorney-in-Fact
Issuer symbol
ATRA
Transactions as of
04 Nov 2021
Net transactions value
-$260,403
Form type
4
Filing time
05 Nov 2021, 16:28:37 UTC
Previous filing
03 Nov 2021
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $260,403 -13,354 -30% $19.50 31,500 04 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction pursuant to Rule 10b5-1 Plan adopted May 14, 2021.